Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02899299 |
|---|---|
| Brief Title: | Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients (CheckMate743) |
| First Submitted : | August 31, 2016 |
| First Submitted that Met QC Criteria : | September 8, 2016 |
| First Posted : | September 14, 2016 (Estimate) |
| Results First Submitted : | March 24, 2021 |
| Results First Submitted that Met QC Criteria : | March 24, 2021 |
| Results First Posted : | April 14, 2021 |
| Last Update Submitted that Met QC Criteria : | June 29, 2023 |
| Last Update Posted : | July 5, 2023 |